In a big boost, Covaxin, Covishield get full market authorisation

Jan 20, 2022, at 06:12 am

New Delhi/IBNS: In a big boost to India's fight against COVID-19, an expert panel of the central drug authority on Wednesday cleared the country's two indigenous vaccines-Covaxin and Covishield-for full use.

India reports 41,195 new COVID-19 cases in 24 hours

Aug 12, 2021, at 04:27 pm

New Delhi/IBNS: In another spike in daily COVID-19 cases, India Thursday reported 41,195 new infections while the toll went up by 490 in the last 24 hours.

COVID-19 vaccine: Bharat Biotech submits Covaxin phase 3 trial data to DGCI, say reports

Jun 22, 2021, at 07:22 pm

New Delhi/IBNS: Hyderabad-based drug manufacturer Bharat Biotech has submitted the phase three clinical trial data of its anti-COVID-19 vaccine, Covaxin, to the Drug Controller General of India (DGCI), media reports said.

'Well established' foreign COVID-19 vaccines makers need no bridging clinical trials in India

Jun 02, 2021, at 06:38 pm

New Delhi/IBNS: The Indian government has exempted "well established" foreign COVID-19 vaccines makers from any bridging clinical trials if it has been certified by the National Control Lab of the country where it is made, media reports said.

Indian drug regulator DGCI clears Covaxin phase 2, 3 clinical trials for children

May 13, 2021, at 05:08 pm

New Delhi/IBNS: India's drug regulator body has cleared the second and third phase of clinical trials of indigenous anti-Covid-19 vaccine, Covaxin, for children, media reports said.

India reports 3.62 lakh new Covid-19 cases, over 4,000 deaths in 24 hours

May 13, 2021, at 04:46 pm

New Delhi/IBNS: More than 3.62 lakh new Covid-19 cases and over 4,000 deaths apparently due to the virus were reported in massively Coronavirus-hit Asian country India on Thursday.